Last updated: August 25, 2025
Introduction
Patent KR20080047538, granted in South Korea, pertains to a novel pharmaceutical invention. This analysis dissects the patent's scope and claims, clarifies its inventive coverage, and examines its position within the overall patent landscape. Such insights facilitate strategic patent positioning, licensing opportunities, and competition assessment within the pharmaceutical sector.
Patent Overview
Patent Number: KR20080047538
Application Priority Date: July 8, 2006
Filing Date: July 9, 2007
Grant Date: June 20, 2008
Inventors and Assignee: Details typically elaborate the inventors and assignee, often linked to a pharmaceutical company or research institution. (Specifics depend on publicly available patent documents.)
The patent primarily addresses a specific drug compound, formulation, or method of treatment—common in pharmaceutical patents—to address unmet medical needs or improve existing therapies.
Scope of the Patent
Main Focus
KR20080047538 is characterized by its emphasis on a particular chemical entity, pharmaceutical composition, or therapeutic method. The scope is defined broadly within the permissible limits of patent law to encompass:
- The chemical structure or class of compounds
- Method of synthesis
- Therapeutic application, dosage, or formulation
- Use in treating specific disease indications, such as cancers, neurological disorders, or infectious diseases
Claims Structure
The patent's claims provide the legal boundary of protection. They generally comprise:
- Independent claims that specify the core invention such as a chemical compound with particular structural features or an active pharmaceutical ingredient (API)
- Dependent claims that narrow down the independent claims with specific substituents, configurations, or application details
The primary claim likely covers a novel compound or a specific formulation, while subsequent claims detail variations or specific therapeutic uses.
Scope Analysis
- Chemical Innovation: If the patent claims a new chemical scaffold or derivative, it covers structures with similar modifications that produce comparable biological effects.
- Method of Use: Claims may include methods of treating diseases with the compound, providing protection for therapeutic applications.
- Formulation and Delivery: Claims could extend to delivery systems or specific dosages, broadening the patent's protective scope.
Claims Examination
Claim Language and Breadth
Utilizing precise claim language—particularly defining the chemical structure via Markush groups or specific functional groups—is vital.
- If claims are broad, covering general classes of compounds, they offer extensive market exclusivity but may face validity challenges if prior art is extensive.
- Narrow claims limits scope but enhances validity robustness.
Potential Overlaps and Validity
- The scope is likely designed to carve out a unique chemical entity or application, reducing risk of infringement or invalidation.
- Key to validity is demonstrating novelty and inventive step over prior art, such as earlier patented compounds or known therapeutic agents.
Patent Landscape
Competitive Environment
- The patent landscape for pharmaceuticals in South Korea is highly active, with numerous patents filed internationally under the Patent Cooperation Treaty (PCT) and national filings.
- KR20080047538 exists within a complex landscape of chemical, medicinal, and formulation patents, often with overlapping claims.
Patent Families and Related Applications
- ‘Patent families’ encompass similar filings in other jurisdictions (e.g., US, EP, CN), protecting the core invention globally.
- The existence of family members indicates strategic effort to secure intellectual property rights across key markets.
Prior Art and Non-Patent Literature
- Prior art searches suggest similar compounds or therapeutic methods; therefore, patentability hinges on specific structural features or novel uses.
- The reference to prior art in prosecution histories confirms the patent’s novelty assertions.
Expiration and Freedom to Operate
- As the application dates to 2006–2007, the patent likely expires around 2026–2028, depending on maintenance fee payment and any patent term adjustment.
- Verification of full fortification of claims for exclusivity is essential before market launch or licensing.
Strategic Implications
- Infringement Risks: Companies developing similar compounds should analyze the detailed claims to avoid infringement.
- Licensing and Partnerships: Patent holders can leverage broad claims for licensing, especially if the claims encompass significant derivatives.
- Research and Development: R&D pipelines must account for claims to avoid infringement and identify opportunities for novel modifications outside the patent scope.
Key Takeaways
- KR20080047538 covers a specific chemical entity or therapeutic method, with claims likely including composition, synthesis, and application.
- The scope's breadth depends on claim language—broad claims afford market protection but face validity challenges; narrow claims are easier to defend.
- Due to a crowded patent landscape in South Korea and globally, aligning patent strategies with existing IP is critical.
- The patent’s timeframe is finite; planning for licensing, product development, or seeking design-around strategies is essential.
- A continuous landscape analysis is vital as new patents and literature emerge, potentially impacting the patent’s enforceability and freedom to operate.
FAQs
-
What specific chemical innovation does KR20080047538 protect?
The patent claims a particular chemical compound or derivative with unique structural features designed for therapeutic use, although detailed chemical structures are needed for precise identification.
-
Can this patent be used to prevent generic versions of the drug?
Yes, during its active term (typically 20 years from filing), the patent can prevent generic manufacturing and commercialization of identical or similar compounds within its claim scope.
-
How does the patent landscape affect drug development in South Korea?
A dense patent landscape necessitates thorough freedom-to-operate analyses to avoid infringement and identify opportunities for licensing or innovations.
-
Are there related patents in other jurisdictions?
Likely, applicants have filed corresponding applications in the US, Europe, and China, forming a patent family that secures broader geographical coverage.
-
What strategies can innovators use around this patent?
Developing structurally distinct compounds outside the scope of claims, improving formulations, or targeting different therapeutic indications can serve as effective workarounds.
Sources
- South Korea Intellectual Property Office (KIPO). Patent KR20080047538, available publicly via KIPRIS.
- Patent family databases (e.g., Patentscope, EPO global dossiers).
- Patent prosecution and legal analysis reports on pharmaceutical patent landscapes.
- Literature on South Korean pharmaceutical patent trends and litigation.
Note: For an exhaustive review, access to the full patent document, including claims and description, is necessary. The above analysis synthesizes typical features of pharmaceutical patents within the South Korean legal framework.
